Shares of medical technology company Inspire Medical Systems (NYSE:INSP) fell 8.7% in the morning session after the company's ...

Fourth quarter revenue growth of 12% and full year revenue growth of 14%Fourth quarter net income per diluted share of $4.66; adjusted net income ...

The latest update on Inspire Medical Systems tightens the story around its valuation, with the fair value estimate moving ...

Doctors at ENT Head & Neck Specialists have completed the practice’s 100th Berks County procedure of Inspire — an FDA-approved obstructive sleep apnea treatment option for people who cannot use ...

Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 12.2% year on year to $269.1 million. On the other ...

Inspire Medical shares slide 8% as coding change clouds outlook ...

Inspire Medical Systems designs neurostimulation systems that treat moderate to severe OSA in patients who are unable to tolerate continuous positive airway pressure (CPAP) devices. Its core product ...

Detailed price information for Inspire Medical Systems Inc (INSP-N) from The Globe and Mail including charting and trades.

Inspire Medical Systems, Inc. is a Sell due to competitive pressures, reimbursement uncertainties & margin compression. Read more on INSP stock here.